Mechanisms Underlying Atrial Fibrillation

Cardiac Electrophysiology Clinics

Volumn 3, Issue 1, 2011, Pages 141-156

  Rama, David Filgueiras ^a   Jalife, José ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Antiarrhythmic drugs; Atrial fibrillation; Reentry; Rotor dynamics

Indexed keywords

ANTICOAGULANT AGENT; DRONEDARONE;

BRAIN ISCHEMIA; CARDIAC PATIENT; ELECTROCARDIOGRAM; HEALTH CARE; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART VENTRICLE FIBRILLATION; HOSPITALIZATION COST; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; RADIOFREQUENCY ABLATION; REFRACTORY PERIOD; REVIEW; SINUS RHYTHM; STROKE; UNITED STATES;

EID: 78751619042     PISSN: 18779182     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccep.2010.10.003     Document Type: Review

References (87)

1. Kannel W.B., Wolf P.A., Benjamin E.J., et al. Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. Am J Cardiol 1998, 82:2N-9N.
2. Wolf P.A., Abbott R.D., Kannel W.B. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 1991, 22:983-988.
3. Thrall G., Lane D., Carroll D., et al. Quality of life in patients with atrial fibrillation: a systematic review. Am J Med 2006, 119:448.e1-448.e19.
4. Go A.S., Hylek E.M., Phillips K.A., et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 2001, 285:2370-2375.
5. Miyasaka Y., Barnes M.E., Gersh B.J., et al. Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation 2006, 114:119-125.
6. Coyne K.S., Paramore C., Grandy S., et al. Assessing the direct costs of treating nonvalvular atrial fibrillation in the United States. Value Health 2006, 9:348-356.
7. Hohnloser S.H., Crijns H.J., van Eickels M., et al. Effect of dronedarone on cardiovascular events in atrial fibrillation. N Engl J Med 2009, 360:668-678.
8. Zimetbaum P., Reynolds M.R., Ho K.K., et al. Impact of a practice guideline for patients with atrial fibrillation on medical resource utilization and costs. Am J Cardiol 2003, 92:677-681.
9. Lafuente-Lafuente C., Mouly S., Longas-Tejero M.A., et al. Antiarrhythmic drugs for maintaining sinus rhythm after cardioversion of atrial fibrillation: a systematic review of randomized controlled trials. Arch Intern Med 2006, 166:719-728.
10. Kober L., Torp-Pedersen C., McMurray J.J., et al. Increased mortality after dronedarone therapy for severe heart failure. N Engl J Med 2008, 358:2678-2687.
11. Haissaguerre M., Jais P., Shah D.C., et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 1998, 339:659-666.
12. Cappato R., Calkins H., Chen S.A., et al. Worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circulation 2005, 111:1100-1105.
13. Fuster V., Ryden L.E., Cannom D.S., et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 guidelines for the management of patients with atrial fibrillation) developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Europace 2006, 8:651-745.
14. Jahangir A., Lee V., Friedman P.A., et al. Long-term progression and outcomes with aging in patients with lone atrial fibrillation: a 30-year follow-up study. Circulation 2007, 115:3050-3056.
15. Waktare J.E., Hnatkova K., Sopher S.M., et al. The role of atrial ectopics in initiating paroxysmal atrial fibrillation. Eur Heart J 2001, 22:333-339.
16. Allessie M., Ausma J., Schotten U. Electrical, contractile and structural remodeling during atrial fibrillation. Cardiovasc Res 2002, 54:230-246.
17. Morillo C.A., Klein G.J., Jones D.L., et al. Chronic rapid atrial pacing. Structural, functional, and electrophysiological characteristics of a new model of sustained atrial fibrillation. Circulation 1995, 91:1588-1595.
18. Wijffels M.C., Kirchhof C.J., Dorland R., et al. Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circulation 1995, 92:1954-1968.
19. Eijsbouts S., Ausma J., Blaauw Y., et al. Serial cardioversion by class IC Drugs during 4 months of persistent atrial fibrillation in the goat. J Cardiovasc Electrophysiol 2006, 17:648-654.
20. Singer D.E., Albers G.W., Dalen J.E., et al. Antithrombotic therapy in atrial fibrillation: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004, 126:429S-456S.
21. Kopecky S.L., Gersh B.J., McGoon M.D., et al. The natural history of lone atrial fibrillation. A population-based study over three decades. N Engl J Med 1987, 317:669-674.
22. Anumonwo J., Jalife J. Cardiac electrophysiology and arrhythmias. Cardiac electrophysiology and arrhythmias 1991, 35-50. Elsevier, New York. C. Fisch, B. Surawicz (Eds.).
23. Katzung B.G., Morgenstern J.A. Effects of extracellular potassium on ventricular automaticity and evidence for a pacemaker current in mammalian ventricular myocardium. Circ Res 1977, 40:105-111.
24. Ho S.Y., Cabrera J.A., Tran V.H., et al. Architecture of the pulmonary veins: relevance to radiofrequency ablation. Heart 2001, 86:265-270.
25. Anderson K.P., Stinson E.B., Mason J.W. Surgical exclusion of focal paroxysmal atrial tachycardia. Am J Cardiol 1982, 49:869-874.
26. Chen Y.J., Chen S.A., Chang M.S., et al. Arrhythmogenic activity of cardiac muscle in pulmonary veins of the dog: implication for the genesis of atrial fibrillation. Cardiovasc Res 2000, 48:265-273.
27. Takahashi Y., Iesaka Y., Takahashi A., et al. Reentrant tachycardia in pulmonary veins of patients with paroxysmal atrial fibrillation. J Cardiovasc Electrophysiol 2003, 14:927-932.
28. Chen S.A., Hsieh M.H., Tai C.T., et al. Initiation of atrial fibrillation by ectopic beats originating from the pulmonary veins: electrophysiological characteristics, pharmacological responses, and effects of radiofrequency ablation. Circulation 1999, 100:1879-1886.
29. Atienza F., Almendral J., Moreno J., et al. Activation of inward rectifier potassium channels accelerates atrial fibrillation in humans: evidence for a reentrant mechanism. Circulation 2006, 114:2434-2442.
30. Burashnikov A., Antzelevitch C. Reinduction of atrial fibrillation immediately after termination of the arrhythmia is mediated by late phase 3 early afterdepolarization-induced triggered activity. Circulation 2003, 107:2355-2360.
31. 2+ in the heart. Circ Res 2008, 103:509-518.
32. Rostock T., O'Neill M.D., Takahashi Y., et al. Interactions between two simultaneous tachycardias within an electrically isolated pulmonary vein. J Cardiovasc Electrophysiol 2007, 18:441-445.
33. Knecht S., O'Neill M.D., Matsuo S., et al. Focal arrhythmia confined within the coronary sinus and maintaining atrial fibrillation. J Cardiovasc Electrophysiol 2007, 18:1140-1146.
34. Satoh T., Zipes D.P. Cesium-induced atrial tachycardia degenerating into atrial fibrillation in dogs: atrial torsades de pointes?. J Cardiovasc Electrophysiol 1998, 9:970-975.
35. Yamazaki M., Vaquero L.M., Hou L., et al. Mechanisms of stretch-induced atrial fibrillation in the presence and the absence of adrenocholinergic stimulation: interplay between rotors and focal discharges. Heart Rhythm 2009, 6:1009-1017.
36. Cerrone M., Noujaim S.F., Tolkacheva E.G., et al. Arrhythmogenic mechanisms in a mouse model of catecholaminergic polymorphic ventricular tachycardia. Circ Res 2007, 101:1039-1048.
37. Mansour M., Mandapati R., Berenfeld O., et al. Left-to-right gradient of atrial frequencies during acute atrial fibrillation in the isolated sheep heart. Circulation 2001, 103:2631-2636.
38. Kalifa J., Jalife J., Zaitsev A.V., et al. Intra-atrial pressure increases rate and organization of waves emanating from the superior pulmonary veins during atrial fibrillation. Circulation 2003, 108:668-671.
39. Samie F.H., Berenfeld O., Anumonwo J., et al. Rectification of the background potassium current: a determinant of rotor dynamics in ventricular fibrillation. Circ Res 2001, 89:1216-1223.
40. Allessie M.A., Bonke F.I., Schopman F.J. Circus movement in rabbit atrial muscle as a mechanism of tachycardia. Circ Res 1973, 33:54-62.
41. Jalife J., Berenfeld O. Molecular mechanisms and global dynamics of fibrillation: an integrative approach to the underlying basis of vortex-like reentry. J Theor Biol 2004, 230:475-487.
42. Wellner M., Berenfeld O., Jalife J., et al. Minimal principle for rotor filaments. Proc Natl Acad Sci U S A 2002, 99:8015-8018.
43. Berenfeld O., Mandapati R., Dixit S., et al. Spatially distributed dominant excitation frequencies reveal hidden organization in atrial fibrillation in the Langendorff-perfused sheep heart. J Cardiovasc Electrophysiol 2000, 11:869-879.
44. Mandapati R., Skanes A., Chen J., et al. Stable microreentrant sources as a mechanism of atrial fibrillation in the isolated sheep heart. Circulation 2000, 101:194-199.
45. Berenfeld O., Zaitsev A.V., Mironov S.F., et al. Frequency-dependent breakdown of wave propagation into fibrillatory conduction across the pectinate muscle network in the isolated sheep right atrium. Circ Res 2002, 90:1173-1180.
46. Saito T., Waki K., Becker A.E. Left atrial myocardial extension onto pulmonary veins in humans: anatomic observations relevant for atrial arrhythmias. J Cardiovasc Electrophysiol 2000, 11:888-894.
47. Spach M.S., Josephson M.E. Initiating reentry: the role of nonuniform anisotropy in small circuits. J Cardiovasc Electrophysiol 1994, 5:182-209.
48. Arora R., Verheule S., Scott L., et al. Arrhythmogenic substrate of the pulmonary veins assessed by high-resolution optical mapping. Circulation 2003, 107:1816-1821.
49. Kalifa J., Tanaka K., Zaitsev A.V., et al. Mechanisms of wave fractionation at boundaries of high-frequency excitation in the posterior left atrium of the isolated sheep heart during atrial fibrillation. Circulation 2006, 113:626-633.
50. Lazar S., Dixit S., Marchlinski F.E., et al. Presence of left-to-right atrial frequency gradient in paroxysmal but not persistent atrial fibrillation in humans. Circulation 2004, 110:3181-3186.
51. Atienza F., Almendral J., Jalife J., et al. Real-time dominant frequency mapping and ablation of dominant frequency sites in atrial fibrillation with left-to-right frequency gradients predicts long-term maintenance of sinus rhythm. Heart Rhythm 2009, 6:33-40.
52. Sanders P., Berenfeld O., Hocini M., et al. Spectral analysis identifies sites of high-frequency activity maintaining atrial fibrillation in humans. Circulation 2005, 112:789-797.
53. Sahadevan J., Ryu K., Peltz L., et al. Epicardial mapping of chronic atrial fibrillation in patients: preliminary observations. Circulation 2004, 110:3293-3299.
54. Lewis T. The mechanism and graphic registration of the heart beat 1925, 319-374. Shaw, London. 3rd edition.
55. Garrey W.E. Auricular fibrillation. Physiol Rev 1924, 4:215.
56. Lewis T., Fell H.S., Stroud W.D. Observations upon flutter and fibrillation. II. The nature of auricular flutter. Heart 1920, 7:191-233.
57. Scherf D. Studies on auricular tachycardia caused by aconitine administration. Proc Soc Exp Biol Med 1947, 64:233-239.
58. Moe G.K., Abildskov J.A. Atrial fibrillation as a self-sustaining arrhythmia independent of focal discharge. Am Heart J 1959, 58:59-70.
59. Moe G.K., Rheinboldt W.C., Abildskov J.A. A computer model of atrial fibrillation. Am Heart J 1964, 67:200-220.
60. Allessie M.A., Lammers W.E., Bonke F.I., et al. Experimental evaluation of Moe's multiple wavelet hypothesis of atrial fibrillation. Cardiac electrophysiology and arrhythmias 1985, 265-275. Grune & Stratton, Orlando. D.P. Zipes, J. Jalife (Eds.).
61. Cox J.L. The surgical treatment of atrial fibrillation. IV. Surgical technique. J Thorac Cardiovasc Surg 1991, 101:584-592.
62. Gray R.A., Jalife J., Panfilov A.V., et al. Mechanisms of cardiac fibrillation. Science 1995, 270:1222-1223. [author reply: 4-5].
63. Hocini M., Nault I., Wright M., et al. Disparate evolution of right and left atrial rate during ablation of long-lasting persistent atrial fibrillation. J Am Coll Cardiol 2010, 55:1007-1016.
64. Delmar M., Duffy H.S., Soren P.L., et al. Molecular organization and regulation of the cardiac gap junction channel connexin43. Cardiac electrophysiology: from cell to bedside 2004, 66-76. Saunders, Philadelphia. 4th edition. D.P. Zipes, J. Jalife (Eds.).
65. Keldermann R.H., ten Tusscher K.H., Nash M.P., et al. A computational study of mother rotor VF in the human ventricles. Am J Physiol Heart Circ Physiol 2009, 296:H370-H379.
66. Cabo C., Pertsov A.M., Davidenko J.M., et al. Vortex shedding as a precursor of turbulent electrical activity in cardiac muscle. Biophys J 1996, 70:1105-1111.
67. Jalife J., Pandit S.V. Ionic mechanisms of wavebreak in fibrillation. Heart Rhythm 2005, 2:660-663.
68. Fast V.G., Kleber A.G. Role of wavefront curvature in propagation of cardiac impulse. Cardiovasc Res 1997, 33:258-271.
69. Beaumont J., Davidenko N., Davidenko J.M., et al. Spiral waves in two-dimensional models of ventricular muscle: formation of a stationary core. Biophys J 1998, 75:1-14.
70. + current (I K1) in the mouse heart accelerates and stabilizes rotors. J Physiol 2007, 578:315-326.
71. Sarmast F., Kolli A., Zaitsev A., et al. Cholinergic atrial fibrillation: I(K, ACh) gradients determine unequal left/right atrial frequencies and rotor dynamics. Cardiovasc Res 2003, 59:863-873.
72. Kneller J., Kalifa J., Zou R., et al. Mechanisms of atrial fibrillation termination by pure sodium channel blockade in an ionically-realistic mathematical model. Circ Res 2005, 96:e35-e47.
73. Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. The Cardiac Arrhythmia Suppression Trial (CAST) Investigators. N Engl J Med 1989, 321:406-412.
74. Samie F.H., Mandapati R., Gray R.A., et al. A mechanism of transition from ventricular fibrillation to tachycardia: effect of calcium channel blockade on the dynamics of rotating waves. Circ Res 2000, 86:684-691.
75. Bollmann A., Sonne K., Esperer H.D., et al. Patients with persistent atrial fibrillation taking oral verapamil exhibit a lower atrial frequency on the ECG. Ann Noninvasive Electrocardiol 2002, 7:92-97.
76. Meurling C.J., Ingemansson M.P., Roijer A., et al. Attenuation of electrical remodelling in chronic atrial fibrillation following oral treatment with verapamil. Europace 1999, 1:234-241.
77. Lakireddy V., Bub G., Baweja P., et al. The kinetics of spontaneous calcium oscillations and arrhythmogenesis in the in vivo heart during ischemia/reperfusion. Heart Rhythm 2006, 3:58-66.
78. Wang Z., Fermini B., Nattel S. Delayed rectifier outward current and repolarization in human atrial myocytes. Circ Res 1993, 73:276-285.
79. + current in heart: molecular basis, functional diversity, and contribution to repolarization. Acta Pharmacol Sin 2004, 25:137-145.
80. Munoz V., Grzeda K.R., Desplantez T., et al. Adenoviral expression of IKs contributes to wavebreak and fibrillatory conduction in neonatal rat ventricular cardiomyocyte monolayers. Circ Res 2007, 101:475-483.
81. Chen Y.H., Xu S.J., Bendahhou S., et al. KCNQ1 gain-of-function mutation in familial atrial fibrillation. Science 2003, 299:251-254.
82. Firek L., Giles W.R. Outward currents underlying repolarization in human atrial myocytes. Cardiovasc Res 1995, 30:31-38.
83. Ehrlich J.R., Nattel S. Novel approaches for pharmacological management of atrial fibrillation. Drugs 2009, 69:757-774.
84. Feng J., Xu D., Wang Z., et al. Ultrarapid delayed rectifier current inactivation in human atrial myocytes: properties and consequences. Am J Physiol 1998, 275:H1717-H1725.
85. Burashnikov A., Antzelevitch C. Can inhibition of IKur promote atrial fibrillation?. Heart Rhythm 2008, 5:1304-1309.
86. Yehia A.R., Shrier A., Lo K.C., et al. Transient outward current contributes to Wenckebach-like rhythms in isolated rabbit ventricular cells. Am J Physiol 1997, 273:H1-11.
87. Blaauw Y., Gogelein H., Tieleman R.G., et al " Early" class III drugs for the treatment of atrial fibrillation: efficacy and atrial selectivity of AVE0118 in remodeled atria of the goat. Circulation 2004, 110:1717-1724.